Why the study?
Understanding the effect of epigenetic regulation mechanisms on cardiovascular disease could advance the field and promote prophylactic methods targeting epigenetic mechanisms in myocardial infarction.
Key points are not available for this paper at this time.
Design
Review
Epigenetic insights may inform MI risk stratification; leaves open whether targeting these mechanisms improves outcomes.
Myocardial infarction (MI) is a complicated pathology triggered by numerous environmental and genetic factors. Understanding the effect of epigenetic regulation mechanisms on the cardiovascular disease would advance the field and promote prophylactic methods targeting epigenetic mechanisms. Genetic screening guides individualised MI therapies and surveillance. The present review reported the latest development on the epigenetic regulation of MI in terms of DNA methylation, histone modifications, and microRNA-dependent MI mechanisms and the novel therapies based on epigenetics.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: